Researchers presenting at ASTRO 2015, the premier radiation oncology scientific event in the world, unveiled new data this week that could fundamentally change the way that early stage breast cancer is treated.
Results from a landmark prospective, randomized, multicenter phase III study conducted in Europe demonstrated that APBI brachytherapy leads to equivalent overall survival and local cancer control rates as compared to WBI after breast conserving surgery for selected patients with early stage breast cancers. These data were presented during the ASTRO official press conference and published in The Lancet, a leading high-impact global peer-reviewed medical journal.
“We have been confidently offering APBI brachytherapy to selected women for years based on numerous phase II, single site and large registry studies that have confirmed the clinical utility of site-specific radiation delivered in a condensed timeframe,” said Frank A. Vicini, M.D., radiation oncologist, 21st Century Oncology, Royal Oak, Mich. and contributing author to the 2009 and 2013 ASTRO and ABS APBI guidelines. “The results from this landmark, multicenter, prospective randomized clinical study are the first to offer the critical level one evidence necessary to drive the fundamental changes in breast conserving cancer treatment that patients and healthcare professionals have been demanding for years.”
To view the multimedia release go to:
http://www.multivu.com/players/uk/7661231-new-apbi-brachytherapy-data-at-astro-2015/
Envision a wireless experience with maximum data rates and no dropped calls at cell edges. Envision limited service areas being a thing of the past. Envision lower costs and greener solutions for base stations. Now, envision the technology that makes all of this is possible. Texas Instruments Incorporated (TI) (NASDAQ: TXN) today is unveiling the industry’s most comprehensive wireless infrastructure System-on-Chip (SoC), featuring an ideal mix of processing elements for both ultra-high capacity small cell and macro base stations. TI’s scalable TMS320TCI6636 delivers breakthrough performance, simultaneous 3G and 4G coverage and capacity expansion features that wireless operators and their users will love. For more information please visit www.ti.com/multicore.
To view Multimedia News Release, go to http://www.multivu.com/mnr/54042-texas-instruments-ti-multi-standard-soc-ultra-high-capacity
The II Moscow International Forum for Innovative Development “Open Innovations”, which was held in Moscow from October 31 to November 1, 2013, confirmed its role of a global discussion platform in the field of technological innovations.
For two consecutive years now, “Open Innovations” has become the largest event in Russia and one of the biggest events in the world, demonstrating the major trends and key developments in innovative sectors of the economy. Open Innovations Expo 2013, which exposition has become a unique platform for the development and demonstration of advanced technologies, exchange of experience in successful implementing of innovative projects, as well as effective interaction between government, science and business was held within the framework of the Forum.
To view the Multimedia News Release, go to http://www.multivu.com/mnr/63505-results-open-innovations-forum-moscow-2013
Researchers presenting at ASTRO 2015, the premier radiation oncology scientific event in the world, unveiled new data this week that could fundamentally change the way that early stage breast cancer is treated.
Results from a landmark prospective, randomized, multicenter phase III study conducted in Europe demonstrated that APBI brachytherapy leads to equivalent overall survival and local cancer control rates as compared to WBI after breast conserving surgery for selected patients with early stage breast cancers. These data were presented during the ASTRO official press conference and published in The Lancet, a leading high-impact global peer-reviewed medical journal.
“We have been confidently offering APBI brachytherapy to selected women for years based on numerous phase II, single site and large registry studies that have confirmed the clinical utility of site-specific radiation delivered in a condensed timeframe,” said Frank A. Vicini, M.D., radiation oncologist, 21st Century Oncology, Royal Oak, Mich. and contributing author to the 2009 and 2013 ASTRO and ABS APBI guidelines. “The results from this landmark, multicenter, prospective randomized clinical study are the first to offer the critical level one evidence necessary to drive the fundamental changes in breast conserving cancer treatment that patients and healthcare professionals have been demanding for years.”
To view the multimedia release go to:
http://www.multivu.com/players/uk/7661231-new-apbi-brachytherapy-data-at-astro-2015/
PBS’s NATIONAL MEMORIAL DAY CONCERT, the iconic event that has become a national tradition, will mark its 25th anniversary with a special tribute to our men and women in uniform, their families at home and all those who have given their lives for our country. Live from the West Lawn of the U.S. Capitol, the inspiring night of remembrance will offer veterans from Afghanistan the grateful thanks of our nation, commemorate the 70th anniversary of World War II’s D-Day invasion on the beaches of Normandy, and look back at the stories of service and sacrifice featured throughout the years during the annual concert.
To view the Multimedia News Release, go to: http://www.multivu.com/mnr/7124751-pbs-national-memorial-day-concert-marks-25-th-anniversary-in-capitol
On the eve of Memorial Day, the 24th annual NATIONAL MEMORIAL DAY CONCERT will bring to life the moving stories of America’s servicemen and women who have given so much to preserve America’s freedoms. The inspiring television event will pay tribute to the profound heroism of all who served during World War II, salute the valor of our Korean War veterans, and honor the sacrifices of our National Guard heroes and their families.
To view Multimedia News Release, go to http://www.multivu.com/mnr/58830-pbs-national-memorial-day-concert-a-special-night-of-remembrance-may-25
Paradox Interactive and Neocore Games today announced that development for King Arthur II is underway. Critically praised by reviewers and gamers alike, King Arthur was received as one of the biggest surprises to emerge on the gaming scene in 2009. The Fantasy/Role-playing RTS returns in a sequel set to push the boundaries of the genre even further.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/prne/paradoxinteractive/47581/
With through this series of very short films, it was a question above
all of making a exercise of style: an idea, a sequence shot, a range,
a recurring character. A whole program thus... The absurdity thus comes to be grafted with this exercise and makes it possible these three a little eccentric ideas to become small well shifted films.
A film by Cyril Cohen
featuring
Cyrial Legaucher
TECHNIKAL:
Written & Directed by: Cyril Cohen
Production : Barbecue Films
Executive Producers: Cyril Cohen / Didier-Victor Cohen / Emmanuel Murat
Photography: Ami Cohen
Sound : Barbecue Films
Editing : Didier Victor Cohen
This Oceanfast 123’ motoryacht carries 4 staterooms with an on-deck master. Having undergone a major refit in 2012 including a complete paint job she shows in excellent condition and ready to go cruising. Powered by twin MTU 8V396 TE94 with the W5's completed in 2012. Perseverance II offers the interior volume and exterior space comparable to much larger yachts. Niad stabilizers, KVH V-Sat television, on-deck master, sky-lounge, tender garage and spacious sun-deck, Perseverance II stands alone in her class. Under the present ownership, she has spent a considerable amount of time cruising the East Coast, Caribbean and Great Lakes.
